Walvax Biotechnology Hits Day High with Strong 5.83% Intraday Surge

Walvax Biotechnology Co., Ltd. has experienced a significant uptick in its stock performance, gaining 5.83% on August 26, 2026. The stock reached an intraday high of CNY 15.97, reflecting a strong day of trading for the large-cap pharmaceutical and biotechnology company. In terms of performance metrics, Walvax has shown impressive results over various time frames. Over the past week, the stock surged by 21.11%, and it has delivered a remarkable 27.81% increase over the past month. Year-to-date, the stock has risen by 39.87%, significantly outperforming the China Shanghai Composite, which has seen a decline of 1.42% during the same period. Despite some long-term growth challenges, the company reported positive financial indicators in its latest quarterly results, including a return on capital employed (ROCE) of 3.39% and a pre-tax profit of CNY 148.23 million. With a price-to-book ratio of 2.80 and a dividend yield of 1.20%, Walvax Biotechnology continues to maintain a notable position within its industry.